Page 3 - Collective Coordinates News Today

ProMIS Neurosciences (NASDAQ:PMN – Get Free Report) and Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Earnings & Valuation This table compares ProMIS […]

Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) and ProMIS Neurosciences (NASDAQ:PMN – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Profitability This table compares Onconova Therapeutics and […]

ProMIS Neurosciences, Inc. (TSE:PMN – Get Free Report)’s share price dropped 13.2% during trading on Monday . The stock traded as low as C$3.66 and last traded at C$4.20. Approximately 26,122 shares traded hands during mid-day trading, an increase of 1,096% from the average daily volume of 2,185 shares. The stock had previously closed at […]

ProMIS Neurosciences, Inc. (NASDAQ:PMN – Free Report) was the recipient of a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 200 shares, a decline of 33.3% from the May 31st total of 300 shares. Based on an average trading volume of 3,300 shares, the […]

ProMIS Neurosciences, Inc. (NASDAQ:PMN – Free Report) was the target of a large decline in short interest in June. As of June 15th, there was short interest totalling 200 shares, a decline of 33.3% from the May 31st total of 300 shares. Based on an average trading volume of 3,300 shares, the short-interest ratio is […]

ProMIS Neurosciences, Inc. (NASDAQ:PMN – Free Report) saw a large decrease in short interest in the month of June. As of June 15th, there was short interest totalling 200 shares, a decrease of 33.3% from the May 31st total of 300 shares. Based on an average daily volume of 3,300 shares, the short-interest ratio is […]

TORONTO, Ontario and CAMBRIDGE, Massachusetts - - ProMIS Neurosciences Inc. (TSX: PMN) (NASDAQ: PMNRFXF) (

ProMIS Neurosciences, Inc. (TSE:PMN – Get Rating)’s stock price rose 0.7% during mid-day trading on Monday . The company traded as high as C$7.10 and last traded at C$7.05. Approximately 227 shares were traded during trading, a decline of 88% from the average daily volume of 1,917 shares. The stock had previously closed at C$7.00. […]

TORONTO, Ontario and CAMBRIDGE, Massachusetts - - ProMIS Neurosciences Inc. , a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded... | May 16, 2023

15.05.2023 - Received FDA clearance for investigational new drug (IND) application for lead therapeutic candidate, PMN310, in Alzheimer’s diseasePresented preclinical data supporting target identification and candidate differentiation across pipeline of antibody ...